Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sung Min | - |
dc.contributor.author | Kim, Kyu Nam | - |
dc.contributor.author | Kim, Soo Yeon | - |
dc.date.accessioned | 2022-07-09T01:01:20Z | - |
dc.date.available | 2022-07-09T01:01:20Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2019-11 | - |
dc.identifier.issn | 0001-5792 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/146837 | - |
dc.description.abstract | Glanzmann thrombasthenia is an uncommon hereditary disease that involves an abnormal platelet function leading to complicated hemostatic problems. In situations of anticipated hemorrhage, irradiated apheresed platelets are the first line of treatment. In addition, a combination of recombinant factor VIIa and an antifibrinolytic agent such as tranexamic acid can be utilized to minimize bleeding. Here we are present stable management of a pediatric patient with Glanzmann thrombasthenia admitted for traumatic epidural hematoma removal. Due to the condition of the operation site, some blood loss was unavoidable. However, hemostasis was successfully controlled, and the patient was discharged without additional complications. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KARGER | - |
dc.title | Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Kyu Nam | - |
dc.identifier.doi | 10.1159/000499362 | - |
dc.identifier.scopusid | 2-s2.0-85065957164 | - |
dc.identifier.wosid | 000495677400009 | - |
dc.identifier.bibliographicCitation | ACTA HAEMATOLOGICA, v.142, no.4, pp.244 - 248 | - |
dc.relation.isPartOf | ACTA HAEMATOLOGICA | - |
dc.citation.title | ACTA HAEMATOLOGICA | - |
dc.citation.volume | 142 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 244 | - |
dc.citation.endPage | 248 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordPlus | RECOMBINANT FACTOR-VIIA | - |
dc.subject.keywordPlus | SURGERY | - |
dc.subject.keywordAuthor | Glanzmann thrombasthenia | - |
dc.subject.keywordAuthor | Antifibrinolytic agents | - |
dc.subject.keywordAuthor | Recombinant factor VIIa | - |
dc.identifier.url | https://www.karger.com/Article/FullText/499362 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.